Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEtreat study of benzydamine + econazole vaginal pessary for uncomplicated vulvovaginal candidosis
2016-002808-19Phase 3Completed
- Sponsor
- Angelini Pharma
- Start
- Jul 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of benzydamine and econazole in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Angelini Pharma. Primary endpoints: Microbiological efficacy and Clinical efficacy. Started Jul 2017; status: completed.
02
Drugs
benzydamineeconazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2016-002808-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002808-19.